Clinical outcome at the 30 day and one year follow up according to intention to treat and actual treatment analysis
| Intention to treat* | RR (95% CI) | Actual treatment* | RR (95% CI) | |||
|---|---|---|---|---|---|---|
| Stent (n = 849) | Balloon (n = 834) | Stent (n = 785) | Balloon (n = 763) | |||
| *All comparisons (stent versus balloon groups) not significant. | ||||||
| CI, confidence interval; MACE, major adverse cardiac events (death, reinfarction, or target vessel revascularisation (TVR)); ReMI, recurrent myocardial infarction; RR, relative risk; SAT, subacute thrombosis. | ||||||
| 30 days | ||||||
| Death | 4.2% | 4.8% | 0.86 (0.54 to 1.35) | 3.2% | 4.5% | 0.71 (0.41 to 1.23) |
| ReMI | 5.9% | 4.4% | 1.37 (0.89 to 2.13) | 5.1% | 3.9% | 1.6 (0.87 to 2.92) |
| Death/ReMI | 9.2% | 8.5% | 1.09 (0.78 to 1.52) | 7.5% | 7.7% | 0.99 (0.66 to 1.55) |
| SAT | 3.4% | 2.2% | 1.6 (0.88 to 2.91) | 3.7% | 2.4% | 1.6 (0.88 to 2.91) |
| TVR | 9.1% | 8.4% | 1.09 (0.78 to 1.53) | 6.4% | 6.0% | 1.21 (0.73 to 1.94) |
| MACE | 13% | 13.4% | 0.96 (0.72 to 1.27) | 9.2% | 10.7% | 0.88 (0.61 to 1.28) |
| 1 year | ||||||
| Death | 7.1% | 6.6% | 1.12 (0.76 to 1.66) | 6.0% | 5.9% | 1.03 (0.68 to 1.59) |
| ReMI | 8.4% | 6.8% | 1.33 (0.9 to 1.96) | 7.8% | 6.4% | 1.32 (0.86 to 2.03) |
| Death/ReMI | 14.0% | 12.4% | 1.21 (0.91 to 1.62) | 12.4% | 11.3% | 1.16 (0.84 to 1.59) |
| SAT | 4.5% | 3.0% | 1.52 (0.91 to 2.53) | 4.8% | 3.3% | 1.53 (0.9 to 2.52) |
| TVR | 19.6% | 20.7% | 0.98 (0.78 to 1.22) | 17.3% | 19.3% | 0.89 (0.7 to 1.15) |
| MACE | 26.3% | 27.6% | 0.99 (0.81 to 1.21) | 23.1% | 25.3% | 0.92 (0.74 to 1.14) |